Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic Cancer Non-resectable × Medical Marijuana × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Marijuana Abuse 3 Neoplasms 2 Epilepsy 2 Tourette Syndrome 1 Stress Disorders, Post-Traumatic 1 Sleep Initiation and Maintenance Disorders 1 Severe Acute Respiratory Syndrome 1 Seizures 1 Parkinson Disease 1 Pancreatic Cancer Non-resectable 1 Pain 1 Opioid-Related Disorders 1 Neurodevelopmental Disorders 1 Multiple Sclerosis 1 Marijuana Use 1 Inflammatory Bowel Diseases 1 Hepatitis C 1 Glaucoma 1 Fibromyalgia 1 Depression 1 Crohn Disease 1 Coronavirus Infections 1 Colitis, Ulcerative 1 Chronic Traumatic Encephalopathy 1 Chronic Pain 1 Carcinoma, Hepatocellular 1 COVID-19 1 Brain Injuries, Traumatic 1 Bipolar Disorder 1 Autistic Disorder 1

Interventions

Gemcitabine 2 tremelimumab 1 irinotecan sucrosofate 1 durvalumab 1 Taxes 1 Specimen Handling 1 Radiosurgery 1 Oxaliplatin 1 Medical Marijuana 1 Leucovorin 1 Heavy Ion Radiotherapy 1 Fluorouracil 1 Chemoradiotherapy 1 Capecitabine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06605430 2025-07-29

CanPan-C

HealthPartners Institute

Phase 2 Recruiting

Gastrointestinal

Pancreatic Cancer Non-resectable

Data powered by HemOnc (CC BY 4.0) Colophon ⚡